Shenzhen Hepalink Pharmaceutical Group Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Shenzhen, Guangdong and currently employs 1,926 full-time employees. The company went IPO on 2010-05-06. Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based pharmaceutical company focused on the field of heparin sodium preparations and raw materials, macromolecular drugs contract development manufacturing organization (CDMO) and innovative drug development. The Company’s main products and services include enoxaparin sodium preparations and heparin sodium bulk medicines, enoxaparin sodium bulk medicines, and CDMO services for macromolecular drugs. The firm distributes its products within the domestic market and to overseas markets, including Turkey, Brazil, the United States and others.
Follow-Up Questions
SHEZF 股票的价格表现如何？
SHEZF 的当前价格为 $0，在上个交易日 decreased 了 0%。
Shenzhen Hepalink Pharmaceutical Group Co Ltd 的主要业务主题或行业是什么？
Shenzhen Hepalink Pharmaceutical Group Co Ltd 属于 Pharmaceuticals 行业，该板块是 Health Care
Shenzhen Hepalink Pharmaceutical Group Co Ltd 的市值是多少？
Shenzhen Hepalink Pharmaceutical Group Co Ltd 的当前市值是 $0
Shenzhen Hepalink Pharmaceutical Group Co Ltd 是买入、卖出还是持有？
据华尔街分析师称，共有 3 位分析师对 Shenzhen Hepalink Pharmaceutical Group Co Ltd 进行了分析师评级，包括 0 位强烈买入，0 位买入，2 位持有，3 位卖出，以及 0 位强烈卖出
